VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19
N Engl J Med
.
2023 Jun 22;388(25):2395.
doi: 10.1056/NEJMc2305030.
Authors
Felix Bergmann
1
,
Anselm Jorda
1
,
Markus Zeitlinger
1
Affiliation
1
Medical University of Vienna, Vienna, Austria.
PMID:
37342931
DOI:
10.1056/NEJMc2305030
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Drug Treatment
COVID-19*
Humans
Ritonavir* / therapeutic use
Substances
nirmatrelvir
Ritonavir
GS-621763